Physician profile
Zoe E Weinstein
NPI 1649415423
$775.54
in general payments reported to CMS, 2019-2025
11 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $343 · 2023: $137 · 2024: $54.78 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $211.82 | 2021-2023 | Aveed, Xiaflex |
| Acerus Pharmaceuticals Corporation | $134.10 | 2021-2022 | |
| Antares Pharma, INC. | $107.45 | 2022-2025 | Xyosted |
| Astellas Pharma US INC | $99.50 | 2021-2023 | Myrbetriq |
| Tolmar, INC. | $87.38 | 2023-2025 | Eligard, Jatenzo |
| Verity Pharmaceuticals INC. | $31.89 | 2025 | Tlando |
| Merck Sharp & Dohme LLC | $28.01 | 2024 | Lynparza |
| Halozyme INC | $23.25 | 2023 | |
| Teleflex LLC | $20.78 | 2023 | Urolift |
| Clarus Therapeutics INC. | $17.97 | 2021 | |
| Srs Medical Systems, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.